ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GSK Gsk Plc

1,335.50
0.50 (0.04%)
Last Updated: 08:45:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 0.04% 1,335.50 1,335.00 1,336.00 1,337.50 1,333.00 1,335.00 272,676 08:45:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1889 11.22 55.34B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,335p. Over the last year, Gsk shares have traded in a share price range of 1,282.50p to 1,820.00p.

Gsk currently has 4,145,087,815 shares in issue. The market capitalisation of Gsk is £55.34 billion. Gsk has a price to earnings ratio (PE ratio) of 11.22.

Gsk Share Discussion Threads

Showing 31551 to 31574 of 34075 messages
Chat Pages: Latest  1267  1266  1265  1264  1263  1262  1261  1260  1259  1258  1257  1256  Older
DateSubjectAuthorDiscuss
07/12/2022
15:34
Very happy. Well done all.
purchaseatthetop
07/12/2022
15:29
Brilliant news.
montyhedge
07/12/2022
15:25
BOA comments

“Although we see this as positive for GSK, the key question is whether MDL cases refile elsewhere in state courts,” Bank of America wrote, raising concerns on cases pending in California, which is “generally thought of as a more plaintiff friendly jurisdiction.”

The analysts led by Graham Parry wrote that the decision tossed out about a third of all Zantac claimants and added that most of the remaining cases are pending in Delaware State Court, where the team sees further dismissals due to weaker evidence.

Arguing that the decision halved its base-case Zantac-related liability in the model for GSK (GSK), the analysts raised the price target on the stock to $36.20. However, Bank of America maintains the Underperform rating on GSK due to multiple factors, including a weak pipeline and an upcoming patent cliff.

geckotheglorious
07/12/2022
14:31
Price was £18 before the initial lawsuit news

Jefferies says this ruling get rid of 80% of potential liabilities


Current yield over 5% v 1.99 for Astra


Conviction buy

j777j
07/12/2022
14:29
In @ 1495.6
tradermichael
07/12/2022
13:19
Well nice news for my biggest holding in my pension pot and ISA's
wall street trader
07/12/2022
11:59
Yeah I have an order in for 50% at 1498
tuftymatt
07/12/2022
11:48
Profit takers have mostly got to buy back in. I've rebought at 15.02.
stewart64
07/12/2022
11:16
This is what I assume. This out the way and the fact is UK PLC has another asset all primed for takeover. I do wonder if a bidder emerges how politically toxic it will be. GSK moving out of West London to Switzerland or the States would be quite a sad day for the UK
richie07
07/12/2022
10:40
my thoughts exactly. lots of profit taking this morning
supermarky
07/12/2022
10:28
If the Zantac worry is reversing, perhaps some bidders may emerge?
tradermichael
07/12/2022
10:22
a lot of profit taking but here's hoping BoD come out and start buying shares ;)
ric0chet
07/12/2022
10:17
Didn't buy these to trade. Was happy holding under 1400, and even happier around 1500. Wake me up when it gets to 1800.Long term hold defensive play, with one major hurdle now over.
wallywoo
07/12/2022
10:15
Yeah I agree TM. It's an early Christmas present for many so why not take it.

I am happy to be out right now but will take a position again all be it a smaller one to start off with.

tuftymatt
07/12/2022
10:11
There's much jumping off the ship, more from relief at getting money back than profit taking, I suspect.

Once this is over, the price will likely stabilise.

tradermichael
07/12/2022
10:04
I got 1606 and 1578 this morning sold 45k and just bought back long term. £15.07 Couldn't resist
mj19
07/12/2022
09:45
A bit slow on the trigger this morning. Saw it was at 16 quid, by the time I had logged in and sold it had fallen to 15.875. But as the top was 16.09, fairly pleased with that.
stewart64
07/12/2022
09:43
Extreme profit taking going on so the price will drop accordingly
abdullla
07/12/2022
09:17
I have set a stop loss at 1531 but hopefully it's not hit.

Having averaged down a great deal I don't want to see that gain erode if we go into some sort of year end decline and with the divi to come too that's a good short term return in my mind.

Good luck all and let's hope we start climbing and break 1600 soon 👍🏻


Edit, I got stopped out but am happier today with GSK than I was yesterday which is always the main thing!!

tuftymatt
07/12/2022
09:10
I wonder if the judge wore a wig or a Santa outfit.
pierre oreilly
07/12/2022
09:10
Getting out from profit & going to buy CURY (LSE)
blackhorse23
07/12/2022
08:52
Still 15% down from pre-Zantac stuff...lots of value still to come!
bobo18
07/12/2022
08:30
Daily telegraph buy tip today, along with Haleon.
A positive article.

careful
07/12/2022
08:25
People new something was coming out today I suspect yesterday and sold! Being scared I was fully loaded with GSK shares so cheap and happy to see this
mj19
Chat Pages: Latest  1267  1266  1265  1264  1263  1262  1261  1260  1259  1258  1257  1256  Older

Your Recent History

Delayed Upgrade Clock